|
|
|
MIRA INFORM REPORT
|
Report No. : |
485310 |
|
Report Date : |
13.01.2018 |
IDENTIFICATION DETAILS
|
Name : |
PAR FORMULATIONS PRIVATE LIMITED (w.e.f. 21.02.2012) |
|
|
|
|
Formerly Known
As : |
EDICT PHARMACEUTICALS PRIVATE LIMITED (w.e.f.23.04.2010) NOVEL THERAPEUTICS PRIVATE LIMITED (w.e.f. 24.09.2007) CHK ELECTRONIKS PRIVATE LIMITED (27.07.1989) C.H. KRISHAN AND ASSOCIATES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
9/215, Pudupakkam – Vandalur, Main Road, Pudupakkam, Kelambakkam,
Chennai – 603103, Tamilnadu |
|
Tel. No.: |
91-44-67480000 / 27474516-18 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
22.09.1982 |
|
|
|
|
Com. Reg. No.: |
18-009602 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 17.921 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U33111TN1982PTC009602 |
|
|
|
|
IEC No.: |
Not Available |
|
|
|
|
GSTIN : |
Not Divulged |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACC2463N |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged in the business of Developing and Manufacturing Generic drugs. (Registered activity) |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Maximum Credit Limit : |
USD 5892000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Par Formulations Private Limited is a subsidiary of “Par Pharmaceuticals
Inc, United States”. It was incorporated in the year 1982 and is a manufacturer of pharmaceutical
formulations and provides research and development services in pharmacy. For the financial year ended 2017, the company has achieved revenue
growth of 45.80% as compared to previous year along with decent profit margin
of 11.07%. The sound financial profile of the company is marked by healthy net
worth base along with low debt balance sheet. Rating also takes into account of financial and managerial support
that company receives from its holding entity backed by its well experienced
management team. Business is active. Payments terms are reported to be regular. In view of the aforesaid, the company can be considered for business
dealings at usual trade terms and conditions. |
NOTES : Any query related to this
report can be made on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
Not Available |
|
Rating |
Not Available |
|
Rating Explanation |
Not Available |
|
Date |
Not Available |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 13.01.2017
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
LOCATIONS
|
Registered Office : |
9/215, Pudupakkam – Vandalur, Main Road, Pudupakkam, Kelambakkam, Chennai
– 603103, Tamilnadu, India |
|
Tel. No.: |
91-44-67480000 / 27474516-18 |
|
Mobile No.: |
Not Available |
|
Fax No.: |
91-44-27474519 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory : |
No. 1/58, Padupakkam Village, Vandalur-Kekambakkam Road, Kelambakkam,
Chennai – 603103, Tamilnadu, India |
|
|
|
|
Branch Office : |
Old No. 1/63, New No. 1/58, Padupakkam Village, Vandalur-Kekambakkam
Road, Kelambakkam, Chennai – 603103, Tamilnadu, India |
DIRECTORS
As on 31.03.2017
|
Name : |
Mr. Terrance Joseph Coughlin |
||||||||||||||||
|
Designation : |
Director |
||||||||||||||||
|
Address : |
52, Turtle Point Road, Tuxedo Park, New York - 10987 US |
||||||||||||||||
|
Date of Birth/Age : |
02.11.1965 |
||||||||||||||||
|
Qualification : |
Graduate |
||||||||||||||||
|
Date of Appointment : |
06.03.2017 |
||||||||||||||||
|
DIN No : |
02135498 |
||||||||||||||||
|
Other
Directorship:
|
|||||||||||||||||
|
|
|
||||||||||||||||
|
Name : |
Mr. Jalaj Sharma |
||||||||||||||||
|
Designation : |
Wholetime Director |
||||||||||||||||
|
Address : |
Flat No. 1602, Sovereign Cooperative Housing Society Behind
Galleria Mall, Hiranandani Gardens, Powai, Mumbai – 400076, Maharashtra,
India |
||||||||||||||||
|
Date of Birth/Age : |
24.09.1963 |
||||||||||||||||
|
Qualification : |
Graduate |
||||||||||||||||
|
Experience : |
AEKPS3848E |
||||||||||||||||
|
Date of Appointment : |
26.09.2015 |
||||||||||||||||
|
DIN No : |
02626340 |
||||||||||||||||
|
Other Directorship:
|
|||||||||||||||||
|
|
|
||||||||||||||||
|
Name : |
Mr. Robert Joseph Cobuzzi Jr |
||||||||||||||||
|
Designation : |
Director |
||||||||||||||||
|
Address : |
19 Percy Place Ballsbridge, Dublin 4 Dublin 372 IE |
||||||||||||||||
|
Date of Birth/Age : |
12.09.1964 |
||||||||||||||||
|
Qualification : |
Graduate |
||||||||||||||||
|
Date of Appointment : |
26.09.2016 |
||||||||||||||||
|
DIN No : |
07289746 |
||||||||||||||||
|
Other
Directorship:
|
|||||||||||||||||
MAJOR SHAREHOLDERS
As on 31.03.2017
|
Names of Shareholders |
No. of Shares |
% of Holding |
|
Par Pharmaceutical Inc., U.S.A. |
|
179206 |
|
Par Inc., U.S.A. |
|
1 |
|
Total |
|
179207 |
Equity Share Break up (Percentage of Total Equity)
As on 28.09.2017
|
Category |
Percentage |
|
Promoters (Body corporate) |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged in the business of Developing and Manufacturing Generic drugs. (Registered activity) |
||||||||
|
|
|
||||||||
|
Products / Services
: |
|
||||||||
|
|
|
||||||||
|
Brand Names : |
Not Available |
||||||||
|
|
|
||||||||
|
Agencies Held : |
Not Available |
||||||||
|
|
|
||||||||
|
Exports : |
Not Available |
||||||||
|
|
|
||||||||
|
Imports : |
Not Available |
||||||||
|
|
|
||||||||
|
Terms : |
Not Available |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Not Available |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
|
Auditors : |
|
|
Name : |
Price Waterhouse and Company LLP Chartered Accountants |
|
Address : |
8th Floor Prestige, Palladium Bayan, 129-140, Greams Road, Chennai – 600006, Tamilnadu, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AAFFP3698A |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Holding Company : |
Par Pharmaceuticals Inc, United States |
|
|
|
|
Subsidiary company
: |
(CIN - U24232TN2013PTC093471) |
|
|
|
|
Ultimate Holding
Company : |
Endo Pharmaceuticals PLCM, United States |
|
|
|
|
Fellow Subsidiary
Company : |
Anchen Pharmaceuticals Inc, United States |
CAPITAL STRUCTURE
As on 31.03.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
200000 |
Equity Shares |
INR 100/- each |
INR 20.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
179207 |
Equity Shares |
INR 100/- each |
INR 17.921 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
INR Million]
ABRIDGED
BALANCE SHEET (STANDALONE)
|
SOURCES
OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
17.921 |
17.921 |
17.921 |
|
(b) Reserves & Surplus |
2044.291 |
1747.129 |
1593.343 |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds |
2062.212 |
1765.050 |
1611.264 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
1063.289 |
1063.288 |
0.000 |
|
(b) Deferred tax liabilities
(Net) |
12.387 |
15.140 |
20.255 |
|
(c) Other long term
liabilities |
0.000 |
19.853 |
18.781 |
|
(d) long-term provisions |
24.388 |
18.390 |
12.448 |
|
Total
Non-current Liabilities |
1100.064 |
1116.671 |
51.484 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Trade payables |
441.035 |
237.043 |
356.876 |
|
(c) Other current liabilities |
174.671 |
113.462 |
130.543 |
|
(d) Short-term provisions |
16.549 |
2.996 |
2.103 |
|
Total
Current Liabilities |
632.255 |
353.501 |
489.522 |
|
|
|
|
|
|
TOTAL |
3794.531 |
3235.222 |
2152.270 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
634.749 |
624.155 |
544.941 |
|
(ii) Intangible Assets |
5.642 |
6.962 |
6.397 |
|
(iii) Capital work-in-progress |
45.241 |
11.212 |
5.280 |
|
(iv) Intangible assets under
development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
1763.948 |
1763.948 |
629.302 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
104.282 |
11.538 |
12.890 |
|
(e) Other Non-current assets |
14.757 |
8.616 |
3.207 |
|
Total
Non-Current Assets |
2568.619 |
2426.431 |
1202.017 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
536.838 |
420.907 |
343.979 |
|
(c) Trade receivables |
300.110 |
232.878 |
316.034 |
|
(d) Cash and cash equivalents |
122.505 |
51.571 |
31.974 |
|
(e) Short-term loans and
advances |
105.152 |
72.201 |
258.266 |
|
(f) Other current assets |
161.307 |
31.234 |
0.000 |
|
Total
Current Assets |
1225.912 |
808.791 |
950.253 |
|
|
|
|
|
|
TOTAL |
3794.531 |
3235.222 |
2152.270 |
PROFIT
& LOSS ACCOUNT (STANDALONE)
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Income |
2683.407 |
1840.440 |
1343.282 |
|
|
Other Income |
198.756 |
103.475 |
20.626 |
|
|
TOTAL
|
2882.163 |
1943.915 |
1363.908 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials Consumed |
1392.073 |
979.585 |
666.230 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
81.315 |
(67.229) |
(26.666) |
|
|
Employees benefits expense |
390.341 |
311.503 |
173.811 |
|
|
Other expenses |
317.999 |
299.495 |
299.210 |
|
|
CSR Expenditure |
8.633 |
0.000 |
0.000 |
|
|
TOTAL |
2190.361 |
1523.354 |
1112.585 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
691.802 |
420.561 |
251.323 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
142.024 |
81.599 |
0.936 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
549.778 |
338.962 |
250.387 |
|
|
|
|
|
|
|
Less |
DEPRECIATION/
AMORTISATION |
86.787 |
79.829 |
68.343 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
462.991 |
259.133 |
182.044 |
|
|
|
|
|
|
|
Less |
TAX |
165.829 |
105.347 |
65.109 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
297.162 |
153.786 |
116.935 |
|
|
|
|
|
|
|
|
EARNINGS
IN FOREIGN CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
1641.543 |
1840.440 |
1343.282 |
|
|
TOTAL
EARNINGS |
1641.543 |
1840.440 |
1343.282 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw Materials |
827.083 |
620.999 |
551.702 |
|
|
Components and Stores parts |
16.961 |
49.077 |
10.792 |
|
|
Capital Goods |
33.017 |
73.248 |
6.834 |
|
|
TOTAL
IMPORTS |
877.061 |
743.324 |
569.328 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (INR) |
1658.2 |
858.15 |
652.51 |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
Net cash flows from (used in) operations |
466.796 |
402.604 |
80.617 |
|
Net cash flows from (used in) operating activity |
346.278 |
279.757 |
38.749 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry Debtors / Income * 365 Days) |
40.82 |
46.18 |
85.87 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry
Debtors) |
8.94 |
7.90 |
4.25 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors
/ Purchases * 365 Days) |
115.64 |
88.32 |
195.52 |
|
|
|
|
|
|
Inventory Turnover (Operating Income
/ Inventories) |
1.29 |
1.00 |
0.73 |
|
|
|
|
|
|
Asset Turnover (Operating Income
/ Net Fixed Assets) |
1.01 |
0.65 |
0.45 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing + Current Liabilities) / Total
Assets) |
0.45 |
0.44 |
0.23 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability /
Networth) |
0.52 |
0.60 |
0.00 |
|
|
|
|
|
|
Current Liabilities to Networth (Current
Liabilities / Net Worth) |
0.31 |
0.20 |
0.30 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets
/ Networth) |
0.33 |
0.36 |
0.35 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial
Charges) |
4.87 |
5.15 |
268.51 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) *
100) |
% |
11.07 |
8.36 |
8.71 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total
Assets) * 100) |
% |
7.83 |
4.75 |
5.43 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth)
* 100) |
% |
14.41 |
8.71 |
7.26 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current Assets / Current Liabilities) |
1.94 |
2.29 |
1.94 |
|
|
|
|
|
|
Quick Ratio ((Current Assets
– Inventories) / Current Liabilities) |
1.09 |
1.10 |
1.24 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total
Assets) |
0.54 |
0.55 |
0.75 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity
Capital) |
59.33 |
59.33 |
0.00 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current
Assets / Total Current Liabilities) |
1.94 |
2.29 |
1.94 |
Total Liability = Short-term Debt + Long-term
Debt + Current Maturities of Long-term debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR In
Million |
INR
In Million |
|
Share Capital |
17.921 |
17.921 |
17.921 |
|
Reserves & Surplus |
1593.343 |
1747.129 |
2044.291 |
|
Money received against share
warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
1611.264 |
1765.050 |
2062.212 |
|
|
|
|
|
|
long-term borrowings |
0.000 |
1063.288 |
1063.289 |
|
Short term borrowings |
0.000 |
0.000 |
0.000 |
|
Total
borrowings |
0.000 |
1063.288 |
1063.289 |
|
Debt/Equity
ratio |
0.000 |
0.602 |
0.516 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
1343.282 |
1840.440 |
2683.407 |
|
|
|
37.011 |
45.802 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
1343.282 |
1840.440 |
2683.407 |
|
Profit |
116.935 |
153.786 |
297.162 |
|
|
8.71% |
8.36% |
11.07% |
ABRIDGED
BALANCE SHEET (CONSOLIDATED)
|
SOURCES
OF FUNDS |
|
31.03.2017 |
31.03.2016 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
|
17.921 |
17.921 |
|
(b) Reserves & Surplus |
|
1814.361 |
1613.887 |
|
(c) Money received against
share warrants |
|
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
|
0.000 |
0.000 |
|
Total
Shareholders’ Funds |
|
1832.282 |
1631.808 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
|
1063.289 |
1063.289 |
|
(b) Deferred tax liabilities
(Net) |
|
12.387 |
15.140 |
|
(c) Other long term
liabilities |
|
0.000 |
86.031 |
|
(d) long-term provisions |
|
47.668 |
36.504 |
|
Total
Non-current Liabilities |
|
1123.344 |
1200.964 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
|
0.000 |
0.000 |
|
(b) Trade payables |
|
430.993 |
262.343 |
|
(c) Other current liabilities |
|
593.391 |
311.807 |
|
(d) Short-term provisions |
|
17.018 |
3.914 |
|
Total
Current Liabilities |
|
1041.402 |
578.064 |
|
|
|
|
|
|
TOTAL |
|
3997.028 |
3410.836 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
|
1406.300 |
1459.875 |
|
(ii) Intangible Assets |
|
334.755 |
446.275 |
|
(iii) Capital work-in-progress |
|
191.741 |
19.757 |
|
(iv) Intangible assets under
development |
|
410.857 |
410.857 |
|
(b) Non-current Investments |
|
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
|
12.092 |
2.834 |
|
(d) Long-term Loan and Advances |
|
188.264 |
28.490 |
|
(e) Other Non-current assets |
|
22.572 |
15.796 |
|
Total
Non-Current Assets |
|
2566.581 |
2383.884 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
|
0.000 |
0.000 |
|
(b) Inventories |
|
616.070 |
464.341 |
|
(c) Trade receivables |
|
448.052 |
331.190 |
|
(d) Cash and cash equivalents |
|
141.821 |
64.212 |
|
(e) Short-term loans and
advances |
|
141.776 |
86.126 |
|
(f) Other current assets |
|
82.728 |
81.083 |
|
Total
Current Assets |
|
1430.447 |
1026.952 |
|
|
|
|
|
|
TOTAL |
|
3997.028 |
3410.836 |
PROFIT
& LOSS ACCOUNT (CONSOLIDATED)
|
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
|
|
SALES |
|
|
|
|
|
Income |
|
3548.882 |
2443.888 |
|
|
Other Income |
|
63.665 |
13.442 |
|
|
TOTAL
|
|
3612.547 |
2457.33 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials Consumed |
|
1475.776 |
1060.436 |
|
|
Changes in inventories of finished
goods, work-in-progress and Stock-in-Trade |
|
54.49 |
(93.307) |
|
|
Employees benefits expense |
|
575.856 |
477.844 |
|
|
Other expenses |
|
658.175 |
504.182 |
|
|
TOTAL |
|
2764.297 |
1949.155 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
|
848.25 |
508.175 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
|
132.995 |
81.776 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
|
715.255 |
426.399 |
|
|
|
|
|
|
|
Less |
DEPRECIATION/
AMORTISATION |
|
346.399 |
297.585 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX |
|
368.856 |
128.814 |
|
|
|
|
|
|
|
Less |
TAX |
|
168.381 |
112.678 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX |
|
200.475 |
16.136 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (INR) |
|
1118.68 |
90.04 |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of establishment |
Yes |
|
2] |
Constitution of the entity Incorporation
details |
Yes |
|
3] |
Locality of the entity |
Yes |
|
4] |
Premises details |
No |
|
5] |
Buyer visit details |
-- |
|
6] |
Contact numbers |
No |
|
7] |
Name of the person contacted |
No |
|
8] |
Designation of contact person |
No |
|
9] |
Promoter’s background |
Yes |
|
10] |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11] |
Pan Card No. of Proprietor / Partners |
Yes |
|
12] |
Voter Id Card No. of Proprietor / Partners |
No |
|
13] |
Type of business |
Yes |
|
14] |
Line of Business |
Yes |
|
15] |
Export/import details (if applicable) |
No |
|
16] |
No. of employees |
No |
|
17] |
Details of sister concerns |
No |
|
18] |
Major suppliers |
No |
|
19] |
Major customers |
No |
|
20] |
Banking Details |
Yes |
|
21] |
Banking facility details |
No |
|
22] |
Conduct of the banking account |
-- |
|
23] |
Financials, if provided |
Yes |
|
24] |
Capital in the business |
Yes |
|
25] |
Last accounts filed at ROC, if applicable |
Yes |
|
26] |
Turnover of firm for last three years |
Yes |
|
27] |
Reasons for variation <> 20% |
-- |
|
28] |
Estimation for coming financial year |
No |
|
29] |
Profitability for last three years |
Yes |
|
30] |
Major shareholders, if available |
Yes |
|
31] |
External Agency Rating, if available |
No |
|
32] |
Litigations that the firm/promoter
involved in |
-- |
|
33] |
Market information |
-- |
|
34] |
Payments terms |
No |
|
35] |
Negative Reporting by Auditors in the
Annual Report |
No |
NOTE: Registered office of the company has been shifted from Old No. 1/63, New No. 1/58, Padupakkam Village, Via. Vandalur - Kekambakkam Road, Kelambakkam, Chennai – 603103, Tamilnadu, India to the present address w.e.f. 14.12.2016
GENERAL INFORMATION
The company is engaged in the business of developing and
manufacturing generic branded drugs. The Company is an Export Oriented Unit
(EOU). Effective February 17, 2012, the Company undertakes contract
manufacturing activities and performs Research and Development activities for
Par Pharmaceuticals Inc. USA
STATE OF THE
COMPANY’S AFFAIRS
The Company continues to develop and file ANDAs, and the Company has tech-transferred few products from its holding company for its commercial manufacturing operations during the year. The Company is well poised to increase its commercial production with the expansion plans of its facility and planned investment in additional equipment.
The Company continues to develop and file ANDAs under the direction and control of its holding company. During financial year 2015-2016, 5 ANDAs have been filed with the US FDA.
INDEX
OF CHARGES
|
SNo |
SRN |
Charge Id |
Charge Holder Name |
Date of Creation |
Date of
Modification |
Date of
Satisfaction |
Amount |
Address |
|
1 |
B32618332 |
10206083 |
State Bank of India |
04/02/2010 |
- |
17/02/2012 |
180000000.0 |
Overseas BranchNo.86. Rajaji SalaiChennaiTN600001IN |
|
2 |
B03644580 |
10109950 |
State Bank of India |
06/03/2008 |
- |
14/01/2011 |
150000000.0 |
Overseas BranchNo.86.Rajaji SalaiChennaiTN600001IN |
|
3 |
Y10428849 |
90305922 |
BHARAT OVERSEAS BANK LTD |
28/11/1989 |
- |
06/11/1995 |
2220000.0 |
MADRAS MAIN BRANCHMADRASTN600090IN |
|
4 |
Y10427339 |
90304412 |
BHARAT OVERSEAS BANK LTD |
01/09/1989 |
06/05/1992 |
06/11/1995 |
4000000.0 |
LARGE ADVANCES BRANCHANNA SALAIMADRASTN600082IN |
|
5 |
Y10430130 |
90307203 |
BHARAT OVERSEAS BANK LTD |
29/11/1989 |
03/10/1991 |
06/11/1995 |
9020000.0 |
226 CATHEDRAL ROADMADRASTN600086IN |
|
6 |
Y10427265 |
90304338 |
BHARAT OVERSEAS BANK LTD |
10/01/1989 |
- |
29/11/1989 |
1400000.0 |
226 CATHEDRAL ROADMADRASTN600086IN |
|
7 |
Y10426878 |
90303951 |
BHARAT OVERSEAS BANK LTD |
20/08/1983 |
23/01/1984 |
10/01/1989 |
6500000.0 |
M 64; GREATER KAILASH BRANCHNEW DELHIDL110049IN |
CONTINGENT
LIABILITIES:
(INR in million)
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
|
Claims against company not acknowledged as debt |
270.565 |
0.000 |
|
|
|
|
FIXED ASSETS
- Land
- Building
- Furniture and
Fixture
- Computer
- Plant and
Machinery
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government official
or a family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 63.74 |
|
|
1 |
INR 86.01 |
|
Euro |
1 |
INR 76.14 |
INFORMATION DETAILS
|
Analysis Done by
: |
PYK |
|
|
|
|
Report Prepared
by : |
TRUP |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.